8 Health Care Stocks Whale Activity In Today's Session

BenzingaJan 9 01:35

Maxim Group Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $25

Futu NewsJan 4 06:31 · Ratings

Capricor Therapeutics: Promising Advances in Duchenne Cardiomyopathy Treatment Drive Buy Rating

TipRanksJan 4 04:05 · Ratings

Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock

BenzingaJan 3 03:00

H.C. Wainwright Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $77

Futu NewsJan 3 00:31 · Ratings

Capricor Therapeutics Price Target Maintained With a $77.00/Share by HC Wainwright & Co.

Dow JonesJan 3 00:27 · Ratings